Skip to main content
Free trial

Analyze this stock with AI

Ask AI to research recent events and build a visual report.

Tell your AI:

“Help me set up FinLab and analyze AEHR Aehr Test Systems: https://finlab.finance/en/setup?stock=AEHR”

Run AI in browser

AEHR

Aehr Test Systems Technology As of 2026-06-18
Quality Weak
Valuation Cheaper
Risk High vol
Active signals Active Top-quintile 6-month momentum
115.3 Close (USD)
+194.21% 60-day
  • Quality is weaker than peers. Operating margin is only around the 18th percentile. TTM ROE is about -8.2%.
  • Valuation is cheaper than most peers. TTM P/E is in the 1th percentile, lower than most liquid US common stocks.
  • Recent volatility is elevated. 60-day annualized volatility is in the 95th percentile. Average 20-day dollar volume is about $202.5M.
  • Signals are active now. Top-quintile 6-month momentum currently holds; the tables below show what followed in this stock’s own history.

Factor profile

Factor radar Neutral Valuation
48
ValuationQualityGrowthMomentumRisk / liquidity

Valuation

Indicators in this group are ranked by market percentile; lower valuation and volatility are better.

48 Neutral
TTM P/E -306
Cheap
Price / book 25.5
Expensive
Free-cash-flow yield (%) -0.33
Average

Historical evidence

Signals active now

Each active condition is tested against this stock’s own history and benchmarked versus the S&P 500.

Top-quintile 6-month momentum

Active · now 99.57627118644068%

The stock ranks in the top 20% of the liquid US common-stock universe by 126-day adjusted return.

25 historical occurrences (since 2016-07-26)
Average forward return after Top-quintile 6-month momentum。20-day: Win 60%, Sample 25, Median +5.02%, Excess +13.62%, Beat mkt rate 60%；60-day: Win 62.5%, Sample 24, Median +15.43%, Excess +44.24%, Beat mkt rate 62.5%；120-day: Win 56.5%, Sample 23, Median +15.48%, Excess +108.86%, Beat mkt rate 56.5%

120 days after: historical avg +115.62%

20-day +16.1%
60-day +47.72%
120-day +115.62%
20-day
60-day
120-day
Win
60%
62.5%
56.5%
Sample
25
24
23
Median
+5.02%
+15.43%
+15.48%
Excess
+13.62%
+44.24%
+108.86%
Beat mkt rate
60%
62.5%
56.5%

Over 23 occurrences, 120-day forward avg gained 115.62%, beat the market by 108.86 pts; win rate 56.5%.

Valuation regime and forward returns

Daily TTM P/E is converted into an expanding own-history percentile, then grouped into five valuation regimes. Forward returns use adjusted prices over the next 240 trading days.

PE percentile bandSample days240-day avg returnMedianWin rateAvg excess (vs index)
0-20 18Insufficient data
20-40 You are here1Insufficient data
40-60 0Insufficient data
60-80 0Insufficient data
80-100 0Insufficient data

Quarterly EPS is aligned by SEC filing date before it is forward-filled to daily prices. The expanding percentile uses only information available up to each day.

Current TTM P/E is about 28.02, placing it in the 36.4 own-history percentile, inside the 20-40 bucket.

Valuation × momentum analogs

Each historical day is grouped by own-history P/E tercile and 60-day momentum direction, then tested for the next 120-trading-day adjusted return.

Valuation
Momentum
Cheap (own-history bottom third)
Middle
Expensive (own-history top third)
60-day momentum up
-22.1%
Win rate 8.5% Excess -26.9%
71d
Now
Insufficient data
(0d)
Insufficient data
(0d)
60-day momentum down
-14.5%
Win rate 23.8% Excess -12.6%
63d
Insufficient data
(0d)
Insufficient data
(0d)

Days = trading days in this bucket; returns use adjusted prices, ex-costs. 60-day momentum: direction of this stock's price over the past 60 trading days.

Market-wide momentum baseline

Across 94,737 liquid US common-stock samples, top-quintile 6-month momentum was followed by an average 60-trading-day return of +6.40%, a 58.3% positive-return rate, and +3.10 percentage points of average excess return versus the S&P 500.

Baseline: weekly samples since 2016 where a liquid US common stock ranked in the top quintile by 126-trading-day momentum. Forward return is 60 trading days; excess return is versus S&P 500 (^GSPC).

Signals not active now

Inactive signals still show the stock-specific historical forward-return distribution for context.

52-week adjusted-price high

Pending

Adjusted close first reaches a 252-trading-day high; repeated hits within 20 days count once.

16 times historically; 60-day forward avg +55.66%, win rate 57.1%, beating the market by +53.42 pts on average.

Filed revenue acceleration

Pending

TTM revenue growth is at least 10% and improved versus the prior filed quarter; event date is the SEC filing date.

8 times historically; 60-day forward avg -7.39%, win rate 37.5%, beating the market by -7.97 pts on average.

EPS surprise beat

Pending

Reported EPS beat consensus estimate by at least 5%; event date is the earnings-surprise timestamp.

17 times historically; 60-day forward avg +54.74%, win rate 56.2%, beating the market by +50.96 pts on average.

Free trial

Analyze this stock with AI

Ask AI to research recent events and build a visual report.

Tell your AI:

“Help me set up FinLab and analyze AEHR Aehr Test Systems: https://finlab.finance/en/setup?stock=AEHR”

Run AI in browser

Method and limits

  • Returns use us_price:adj_close, adjusted for splits and dividends where available.
  • Excess returns use world_index:^GSPC as the S&P 500 benchmark proxy.
  • Quarterly fundamentals are aligned to SEC filing dates before daily valuation studies.
  • The promoted universe starts from active NYSE/NASDAQ common stocks, then applies price and dollar-volume gates.
  • Snapshot-only tables such as analyst consensus, DCF, us_ratios, and us_key_metrics are intentionally excluded from historical evidence.
  • Overlapping event windows are descriptive distributions, not independent samples.

This page is for historical data analysis and education only. It is not investment advice. Backtests and historical return distributions do not predict future performance; evaluate risk independently before trading.